Here we report a study in which molecular profiling is performed using targeted next-generation sequencing (NGS) of 94 HER2-positive luminal B BCs to identify the molecular characteristics of HER2-positive luminal B BC in East Asians. Here, ERBB2 is linked to breast cancer.